Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-27

Clinical Trial Update: Adenomyosis and Ulipristal Acetate [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for adenomyosis using ulipristal acetate has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ulipristal acetate (ulipristal acetate)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Adenomyosis | Phase 2 | Status: COMPLETED